Research output per year
Research output per year
- 21 results
Search results
-
2019
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: influence of ruxolitinib, interferon-α2, or combination treatment
Sørensen, A. L., Bjørn, M. E., Riley, C. H., Holmstrøm, M., Andersen, M. H., Svane, I. M., Mikkelsen, S. U., Skov, V., Kjaer, L., Hasselbalch, H. C. & Nielsen, C. H., Oct 2019, In: European Journal of Haematology. 103, 4, p. 351-361Research output: Contribution to journal › Journal article › Research › peer-review
6 Citations (Scopus) -
High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals
Holmström, M. O., Ahmad, S. M., Klausen, U., Bendtsen, S. K., Martinenaite, E., Riley, C. H., Svane, I. M., Kjær, L., Skov, V., Ellervik, C., Pallisgaard, N., Hasselbalch, H. C. & Andersen, M. H., 1 Feb 2019, In: Blood Cancer Journal. 9, 2, p. 8 8.Research output: Contribution to journal › Journal article › Research › peer-review
25 Citations (Scopus) -
2018
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation
Jørgensen, M. A., Holmström, M. O., Martinenaite, E., Riley, C. H., Hasselbalch, H. C. & Andersen, M. H., 2018, In: OncoImmunology. 7, 9, p. e1468957Research output: Contribution to journal › Journal article › Research › peer-review
13 Citations (Scopus) -
Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response
Holmström, M. O., Riley, C. H., Skov, V., Svane, I. M., Hasselbalch, H. C. & Andersen, M. H., 2018, In: OncoImmunology. 7, 6, p. e1433521Research output: Contribution to journal › Journal article › Research › peer-review
27 Citations (Scopus) -
The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy
Holmström, M. O., Martinenaite, E., Ahmad, S. M., Met, Ö., Friese, C., Kjær, L., Riley, C. H., Thor Straten, P., Svane, I. M., Hasselbalch, H. C. & Andersen, M. H., 2018, In: Leukemia. 32, 2, p. 429-437 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
66 Citations (Scopus) -
2017
The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms
Skov, V., Riley, C. H., Thomassen, M., Kjær, L., Stauffer Larsen, T., Bjerrum, O. W., Kruse, T. A. & Hasselbalch, H. C., 2017, In: Leukemia and Lymphoma. 58, 8, p. 1914-1921Research output: Contribution to journal › Journal article › Research › peer-review
15 Citations (Scopus) -
2016
Interferon-α induces marked alterations in circulating regulatory T cells, NK cell subsets and dendritic cells in patients with JAK2(V617F) -positive essential thrombocythemia and polycythemia vera
Riley, C. H., Brimnes, M. K., Hansen, M., Jensen, M. K., Hasselbalch, H. C., Kjaer, L., thor Straten, P. & Svane, I. M., 19 Sep 2016, In: European Journal of Haematology. 97, 1, p. 83-92Research output: Contribution to journal › Journal article › Research › peer-review
24 Citations (Scopus) -
Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera
Utke Rank, C., Weis Bjerrum, O., Larsen, T. S., Kjær, L., de Stricker, K., Riley, C. H. & Hasselbalch, H. C., 2016, In: Leukemia and Lymphoma. 57, 2, p. 348-54Research output: Contribution to journal › Journal article › Research › peer-review
28 Citations (Scopus) -
2015
Expansion of circulating CD56(bright) natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
Riley, C. H., Hansen, M., Brimnes, M. K., Hasselbalch, H. C., Bjerrum, O. W., thor Straten, P., Svane, I. M. & Jensen, M. K., 2015, In: European Journal of Haematology. 94, 3, p. 227-34Research output: Contribution to journal › Journal article › Research › peer-review
39 Citations (Scopus) -
Status og perspektiver for behandling af de kroniske myeloproliferative neoplasier
Translated title of the contribution :Status and perspectives on chronic myeloproliferative neoplasm treatment Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
2014
Transcriptional profiling of whole blood identifies a unique 5-gene signature for myelofibrosis and imminent myelofibrosis transformation
Hasselbalch, H. C., Skov, V., Stauffer Larsen, T., Thomassen, M., Hasselbalch Riley, C., Jensen, M. K., Bjerrum, O. W. & Kruse, T. A., 2014, In: P L o S One. 9, 1, p. e85567Research output: Contribution to journal › Journal article › Research › peer-review
12 Citations (Scopus) -
Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of nrf2 for genomic instability and disease progression
Hasselbalch, H. C., Thomassen, M., Hasselbalch Riley, C., Kjær, L., Stauffer Larsen, T., Jensen, M. K., Bjerrum, O. W., Kruse, T. A. & Skov, V., 2014, In: P L o S One. 9, 11, p. e112786Research output: Contribution to journal › Journal article › Research › peer-review
58 Citations (Scopus) -
2013
Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha
Stauffer Larsen, T., Iversen, K. F., Hansen, E., Mathiasen, A. B., Marcher, C. W., Frederiksen, M. B., Larsen, H., Helleberg, I., Riley, C. H., Bjerrum, O. W., Rønnov-Jessen, D., Møller, M. B., de Stricker, K., Vestergaard, H. & Hasselbalch, H. C., Sep 2013, In: Leukemia Research. 37, 9, p. 1041-5 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
77 Citations (Scopus) -
Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis
Skov, V., Riley, C. H., Thomassen, M., Larsen, T. S., Jensen, M. K., Bjerrum, O. W., Kruse, T. A. & Hasselbalch, H. C., Oct 2013, In: Leukemia and Lymphoma. 54, 10, p. 2269-73 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
35 Citations (Scopus) -
2012
A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden
Kjær, L., Westman, M., Hasselbalch Riley, C., Høgdall, E., Weis Bjerrum, O. & Hasselbalch, H., 2012, In: P L o S One. 7, 3, p. e33100Research output: Contribution to journal › Journal article › Research › peer-review
18 Citations (Scopus) -
Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis
Skov, V., Thomassen, M., Riley, C. H., Jensen, M. K., Bjerrum, O. W., Kruse, T. A., Hasselbalch, H. C. & Larsen, T. S., 2012, In: Experimental Hematology. 40, 9, p. 771-780.e19Research output: Contribution to journal › Journal article › Research › peer-review
50 Citations (Scopus) -
Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: identification of deregulated genes of significance for inflammation and immune surveillance
Skov, V., Larsen, T. S., Thomassen, M., Riley, C. H., Jensen, M. K., Bjerrum, O. W., Kruse, T. A. & Hasselbalch, H. C., 2012, In: Leukemia Research. 36, 11, p. 1387-92 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
53 Citations (Scopus) -
2011
High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis
Riley, C. H., Skov, V., Larsen, T. S., Thomassen, M., Riley, C. H., Jensen, M. K., Bjerrum, O. W. & Kruse, T. A., 2011, In: Leukemia Research. 35, 10, p. 1330-4 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
13 Citations (Scopus) -
Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α
Riley, C. H., Jensen, M. K., Brimnes, M. K., Hasselbalch, H. C., Bjerrum, O. W., Straten, P. T. & Svane, I. M., 2011, In: Blood. 118, 8, p. 2170-3 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
57 Citations (Scopus) -
Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectives
Hasselbalch, H. C., Larsen, T. S., Riley, C. H., Jensen, M. K. & Kiladjian, J-J., 2011, In: Current Drug Targets. 12, 3, p. 392-419 28 p.Research output: Contribution to journal › Journal article › Research › peer-review
40 Citations (Scopus) -
Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis
Skov, V., Larsen, T. S., Thomassen, M., Riley, C. H., Jensen, M. K., Bjerrum, O. W., Kruse, T. A. & Hasselbalch, H. C., 2011, In: European Journal of Haematology. 87, 1, p. 54-60 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
52 Citations (Scopus)